Skip to main content
. Author manuscript; available in PMC: 2014 Jan 7.
Published in final edited form as: Breast Cancer Res Treat. 2008 Mar 9;113(3):10.1007/s10549-008-9953-0. doi: 10.1007/s10549-008-9953-0

Figure 2.

Figure 2

The baseline tumor FES (left) and percent change in tumor FDG (right) uptake after estradiol challenge in patients who responded and who did not respond to endocrine therapy.